A share price of Vera Therapeutics Inc [VERA] is currently trading at $33.75, up 1.26%. In order to assess the stock’s recent performance, you can check whether its short-term value is rising or falling. The VERA shares have gain 21.10% over the last week, with a monthly amount glided 14.95%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Vera Therapeutics Inc [NASDAQ: VERA] stock has seen the most recent analyst activity on October 16, 2025, when BofA Securities initiated its Buy rating and assigned the stock a price target of $48. Previously, Wolfe Research downgraded its rating to Peer Perform on August 04, 2025. Wolfe Research started tracking the stock assigning an Outperform rating and suggested a price target of $49 on February 04, 2025. Goldman initiated its recommendation with a Buy and recommended $58 as its price target on January 28, 2025. Wells Fargo started tracking with an Overweight rating for this stock on November 21, 2024, and assigned it a price target of $70. In a note dated October 16, 2024, Scotiabank initiated an Sector Outperform rating.
Vera Therapeutics Inc experienced fluctuations in its stock price throughout the past year between $18.53 and $51.27. Currently, Wall Street analysts expect the stock to reach $77.5 within the next 12 months. Vera Therapeutics Inc [NASDAQ: VERA] shares were valued at $33.75 at the most recent close of the market. An investor can expect a potential return of 129.63% based on the average VERA price forecast.
Analyzing the VERA fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.38, Equity is -0.47 and Total Capital is -0.43. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.17.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 33.29 points at the first support level, and at 32.83 for the second support level. However, for the 1st resistance point, the stock is sitting at 34.32, and for the 2nd resistance point, it is at 34.89.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Vera Therapeutics Inc [NASDAQ:VERA] is 12.09. In addition, the Quick Ratio stands at 12.09 and the Cash Ratio stands at 1.46.
Transactions by insiders
Recent insider trading involved Carter Jason S, Chief Legal Officer, that happened on Nov 21 ’25 when 3864.0 shares were sold. Officer, Carter Jason S completed a deal on Nov 21 ’25 to buy 3864.0 shares. Meanwhile, SVP, FINANCE, CHIEF ACCT OFFCR Young Joseph R sold 15000.0 shares on Nov 11 ’25.
